LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix International N.V., today announced the realignment of its businesses in order to better focus on operational performance and enhance the Company’s growth potential. The Company’s operational businesses will now include: BioStim (stimulation products), Spine Fixation (spine implant products), Biologics (biologics products for all applications), International Extremity Fixation, and U.S. Extremity Fixation (orthopedic fixation systems).In connection with the realignment, the Global Spine business will be separated into two businesses: BioStim and Spine Fixation. Brad Niemann, currently Orthofix’s Senior Vice President, Commercial Operations has been promoted to President of the BioStim business, effective immediately. Mr. Niemann has more than 15 years of experience in the medical device industry, with a particularly strong focus and track record in expanding the utilization of bone growth stimulation technology. Brad Mason, President and Chief Executive Officer of Orthofix, will assume all senior management duties for the Spine Fixation business on an interim basis. Brian McCollum, currently President of Global Spine, will be leaving the Company on July 15, 2013.
Orthofix today also announced that Mark Atkinson has been named Orthofix’s Chief People Officer, effective immediately. Mr. Atkinson comes to Orthofix with a strong background in organizational development and talent management. In this newly created position, Mr. Atkinson will oversee all human resources management, as well as be responsible for executive and employee development and creating a corporate culture conducive to growth and success.
In addition, the Company announced the appointment of Michael Finegan as Chief Strategy Officer and Jeff Schumm as Chief Administrative Officer. In these newly formed roles, Mr. Finegan will oversee all strategic activities, while Mr. Schumm will supervise all regulatory affairs, legal matters, and government affairs.Mr. Mason continued, “On behalf of Orthofix, I would like to welcome both Mark and Brad to the senior management team, congratulate Mike and Jeff on their expanded roles, and thank Brian for his many contributions and years of service to our Company and wish him success in his future endeavors. We are creating a strong leadership team of talented employees at Orthofix and these promotions and appointments, together with our organization changes will advance our objectives for the benefit of our many stakeholders.”.
About Orthofix
Orthofix International N.V. is a diversified, global medical device company focused on developing and delivering innovative repair and regenerative solutions to the spine and orthopedic markets. Orthofix’s products are widely distributed around the world to surgeons and patients via Orthofix’s sales representatives and its subsidiaries, and via collaborations with other leading orthopedic product companies. In addition, Orthofix is collaborating on R&D activities with leading research and clinical organizations such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, and Texas Scottish Rite Hospital for Children. For more information about Orthofix, please visit www.orthofix.com.